School of Medicine
Showing 511-520 of 726 Results
-
Kimberly Horstman
Clinical Associate Professor, Pediatrics
BioI came late to medicine, entering medical school after a career editing children's educational books. After graduating from USC Keck School of Medicine and completing my residency at Children's Hospital Los Angeles, I worked briefly in the outpatient setting, and then started my career as a Pediatric Hospitalist in 2006. Since 2016, I have functioned primarily as a Neonatal Hospitalist at John Muir Medical Center in Walnut Creek, CA, taking care of well newborns and Level 2 and 3 NICU patients, as well as attending deliveries and performing newborn procedures.
-
Machiko Hosoki
Clinical Assistant Professor, Pediatrics
Current Research and Scholarly InterestsReading problem in bilingual children in elementary school
-
Hitomi Hosoya, MD, PhD
Instructor, Medicine - Blood & Marrow Transplantation
BioDr. Hosoya is fellowship-trained in blood and marrow transplantation, cellular therapy and hematology with the Stanford Medicine Cancer Center and an instructor at Stanford University in the Department of Medicine, Division of Blood & Marrow Transplantation and Cellular Therapy.
Her areas of expertise include transplantation, immunotherapies, and cellular therapies for patients with multiple myeloma and other plasma cell disorders. She diagnoses and treats a range of blood disorders from anemia and hemophilia to cancerous conditions like leukemia and multiple myeloma. For each patient, she prepares a personalized, comprehensive, and compassionate care plan.
Dr. Hosoya’s research is focused on improving cancer diagnostics and therapeutic decision-making in multiple myeloma. She is specifically interested in the genomics of multiple myeloma and its evolution over the course of the disease. Dr. Hosoya is studying the role of circulating tumor DNA (ctDNA) in patients with multiple myeloma and developing tools to detect and quantify tumors and their response to chemotherapy and immunotherapy, with a goal of informing personalized therapies. Dr. Hosoya demonstrated ctDNA is useful in detecting and monitoring tumor, and its prognostic value for patients undergoing CAR T-cell therapy in multiple myeloma. Her ongoing research is focused on applying cell-free DNA sequencing towards sensitive detection of copy number alterations, gene expression inferences, and understanding mechanisms of disease response and resistance in diverse therapies in multiple myeloma.
Dr. Hosoya is a member of the Society for Immunotherapy of Cancer, American Society of Clinical Oncology, American Society of Hematology, and the Japan Team Oncology Program.
